Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCGenital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate adenocarcinoma, prostate cancer, prostate disorderActive, not recruitingPhase 32025-12-18NCT04446117

3 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Exelixis77
Roche-Genentech11
Takeda163

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Exelixis Clinical #261RosarioArgentina1
Exelixis Clinical #262GeelongAustralia1
Exelixis Clinical #263SantiagoChile1
Exelixis Clinical #264TaipeiTaiwan1
Exelixis Clinical #265TaoyuanTaiwan1
Exelixis Clinical #266Kaohsiung CityTaiwan1
Exelixis Clinical #267ParmaItaly1
Exelixis Clinical #268LodzPoland1
Exelixis Clinical #269PisaItaly1
Exelixis Clinical #270MálagaSpain1
Exelixis Clinical Stie #260Saint AlbansAustralia1
Exelixis Site #156SondrioItaly1
Exelixis Site #157Porto AlegreBrazil1
Exelixis Site #158LinzAustria1
Exelixis Site #159ClevelandUnited States1
Exelixis Site #160MontrealCanada1
Exelixis Site #161São PauloBrazil1
Exelixis Site #162WollongongAustralia1
Exelixis Site #163CuritibaBrazil1
Exelixis Site #164LisbonPortugal1
Exelixis Site #165RoeselareBelgium1
Exelixis Site #166MoscowRussia1
Exelixis site #167GyulaHungary1
Exelixis Site #168MeldolaItaly1
Exelixis Site #170PergaminoArgentina1